These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Menopause and cardiovascular disease: the evidence. Rosano GM; Vitale C; Marazzi G; Volterrani M Climacteric; 2007 Feb; 10 Suppl 1():19-24. PubMed ID: 17364594 [TBL] [Abstract][Full Text] [Related]
23. Aldosteronism and hypertension. Calhoun DA Clin J Am Soc Nephrol; 2006 Sep; 1(5):1039-45. PubMed ID: 17699324 [TBL] [Abstract][Full Text] [Related]
24. Non-selective nonsteroidal anti-inflammatory drugs and cardiovascular events: is aldosterone the silent partner in crime? Knights KM; Mangoni AA; Miners JO Br J Clin Pharmacol; 2006 Jun; 61(6):738-40. PubMed ID: 16722838 [TBL] [Abstract][Full Text] [Related]
25. A primer on aldosterone for gynecologists/obstetricians. Pitt B J Reprod Med; 2007 Feb; 52(2 Suppl):153-8. PubMed ID: 17477109 [TBL] [Abstract][Full Text] [Related]
26. Use of aldosterone antagonists in resistant hypertension. Calhoun DA Prog Cardiovasc Dis; 2006; 48(6):387-96. PubMed ID: 16714158 [TBL] [Abstract][Full Text] [Related]
27. Diagnosis and management of primary aldosteronism. Boscaro M; Ronconi V; Turchi F; Giacchetti G Curr Opin Endocrinol Diabetes Obes; 2008 Aug; 15(4):332-8. PubMed ID: 18594273 [TBL] [Abstract][Full Text] [Related]
28. Renal cysts and hypokalemia in primary aldosteronism: results of long-term follow-up after treatment. Novello M; Catena C; Nadalini E; Colussi GL; Baroselli S; Chiuch A; Lapenna R; Bazzocchi M; Sechi LA J Hypertens; 2007 Jul; 25(7):1443-50. PubMed ID: 17563567 [TBL] [Abstract][Full Text] [Related]
29. [Prevention and treatment of hypertension and coronary heart disease]. Mendoza-González C; Rosas M; Estrada CL; Lorenzo JA; Méndez A; Martínez-Reding J; Martínez-Sánchez C; Pastelín G; Férez-Santander SM; Attie F Arch Cardiol Mex; 2008; 78 Suppl 2():S2-58-73. PubMed ID: 18938686 [TBL] [Abstract][Full Text] [Related]
30. Resistant hypertension and aldosterone excess: new insights from ambulatory blood pressure monitoring. Grassi G; Whitworth JA J Hypertens; 2007 Oct; 25(10):2006-7. PubMed ID: 17885540 [No Abstract] [Full Text] [Related]
31. Efficacy of drug therapy in the secondary prevention of cardiovascular disease and stroke. Fletcher GF; Bufalino V; Costa F; Goldstein LB; Jones D; Smaha L; Smith SC; Stone N Am J Cardiol; 2007 Mar; 99(6C):1E-35E. PubMed ID: 17378996 [No Abstract] [Full Text] [Related]
32. [Preventing cardiovascular diseases--one of the most pressing problem in Russian medicine]. Ter Arkh; 1993; 65(9):3. PubMed ID: 8303590 [No Abstract] [Full Text] [Related]
33. [Aldosterone in patients with chronic circulatory insufficiency]. KODEJSZKO E; KOLINSKA M; KUCZEWSKA K; TATON J Pol Tyg Lek (Wars); 1959 Feb; 14(5):193-6. PubMed ID: 13667539 [No Abstract] [Full Text] [Related]
34. Association of aldosterone and cortisol with cardiovascular risk factors in prehypertension stage. Syed SB; Qureshi MA Int J Hypertens; 2012; 2012():906327. PubMed ID: 22957211 [TBL] [Abstract][Full Text] [Related]
35. Cardiovascular outcomes in patients with primary aldosteronism after treatment. Catena C; Colussi G; Nadalini E; Chiuch A; Baroselli S; Lapenna R; Sechi LA Arch Intern Med; 2008 Jan; 168(1):80-5. PubMed ID: 18195199 [TBL] [Abstract][Full Text] [Related]
36. [Aldosterone blockade in essential hypertension]. Venco A; Grandi AM Ital Heart J; 2005 May; 6 Suppl 1():34S-42S. PubMed ID: 15945298 [TBL] [Abstract][Full Text] [Related]
37. Medical treatment as an alternative to adrenalectomy in patients with aldosterone-producing adenomas. Karagiannis A; Tziomalos K; Kakafika AI; Athyros VG; Harsoulis F; Mikhailidis DP Endocr Relat Cancer; 2008 Sep; 15(3):693-700. PubMed ID: 18586836 [TBL] [Abstract][Full Text] [Related]
38. Cardioprotection by aldosterone receptor antagonism in heart failure. Part I. The role of aldosterone in heart failure. Dieterich HA; Wendt C; Saborowski F Fiziol Cheloveka; 2005; 31(6):97-105. PubMed ID: 16366159 [TBL] [Abstract][Full Text] [Related]
39. Should we consider aldosterone as the primary screening target for preventing cardiovascular events? Francis GS; Tang WH J Am Coll Cardiol; 2005 Apr; 45(8):1249-50. PubMed ID: 15837257 [No Abstract] [Full Text] [Related]